Advanced Medicine

The stem cell industry needs to embrace bioprocess control systems to develop consistent, high quality, and commercially viable bioprocesses.

Sitting Down With… Stanley Crooke, Chairman of the Board & Chief Executive Officer at Ionis Pharmaceuticals.

Successes in the cell and gene therapy field show us that great advances can be made – without taking unnecessary risks.

What does the controversial genome editing work of Jiankui He mean for biomedical research?

A good CDMO is a true partner with advice on getting the most from your molecule.

A fresh take on an existing photography competition aims to display the diversity of science.

Don’t give the journalists an excuse to fuel the hype machine.

Meet Bristol-Myers Squibb’s Bryan (Bo) Barnhart, who is a passionate advocate for the immuno-oncology field.

Regulators step in to stop stem cell clinics from marketing unproven therapies.

The cell therapy industry faces a number of complex problems. Fortunately, they’re good problems to have.